Jin‐Ling Duan

601 total citations
29 papers, 407 citations indexed

About

Jin‐Ling Duan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jin‐Ling Duan has authored 29 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Jin‐Ling Duan's work include RNA modifications and cancer (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer-related gene regulation (5 papers). Jin‐Ling Duan is often cited by papers focused on RNA modifications and cancer (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer-related gene regulation (5 papers). Jin‐Ling Duan collaborates with scholars based in China, United States and Hong Kong. Jin‐Ling Duan's co-authors include Dan Xie, Run‐Cong Nie, Muyan Cai, Feng‐Wei Wang, Shuqiang Yuan, Kai Teng, Minhua Deng, Yun Wang, Rixin Chen and Kai Han and has published in prestigious journals such as Journal of Clinical Oncology, Nature Cell Biology and Oncogene.

In The Last Decade

Jin‐Ling Duan

25 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jin‐Ling Duan China 13 265 139 105 93 52 29 407
Gallina Kazobinka China 11 311 1.2× 148 1.1× 87 0.8× 77 0.8× 23 0.4× 20 405
Xuren Sun China 12 173 0.7× 128 0.9× 117 1.1× 69 0.7× 61 1.2× 25 339
Qijue Lu China 11 342 1.3× 226 1.6× 69 0.7× 82 0.9× 33 0.6× 22 451
Xianyu Hu China 9 225 0.8× 175 1.3× 85 0.8× 102 1.1× 46 0.9× 18 345
Fuao Cao China 12 255 1.0× 113 0.8× 125 1.2× 50 0.5× 61 1.2× 30 381
Juan Ramón Delgado Spain 12 219 0.8× 103 0.7× 151 1.4× 73 0.8× 54 1.0× 24 416
Huohui Ou China 10 280 1.1× 212 1.5× 81 0.8× 97 1.0× 25 0.5× 16 405
Mingyi Ju China 11 301 1.1× 150 1.1× 143 1.4× 170 1.8× 101 1.9× 17 439

Countries citing papers authored by Jin‐Ling Duan

Since Specialization
Citations

This map shows the geographic impact of Jin‐Ling Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin‐Ling Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin‐Ling Duan more than expected).

Fields of papers citing papers by Jin‐Ling Duan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin‐Ling Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin‐Ling Duan. The network helps show where Jin‐Ling Duan may publish in the future.

Co-authorship network of co-authors of Jin‐Ling Duan

This figure shows the co-authorship network connecting the top 25 collaborators of Jin‐Ling Duan. A scholar is included among the top collaborators of Jin‐Ling Duan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin‐Ling Duan. Jin‐Ling Duan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nie, Run‐Cong, Xiaojiang Chen, Chengcai Liang, et al.. (2025). Safety and efficacy of perioperative dual PD-1 and HER2 blockade in HER2-positive gastric cancer. Cell Reports Medicine. 6(6). 102190–102190. 1 indexed citations
2.
Chen, Rixin, Jianguo Wu, Minhua Deng, et al.. (2025). m6A-mediated circG3BP1 translocation to stress granules promotes nucleation and senescence-linked chemoresistance. Cell Reports. 44(10). 116375–116375.
3.
Meng, Jiajia, Xinke Zhang, Xiaobo Wen, et al.. (2025). An end-to-end multifunctional AI platform for intraoperative diagnosis. npj Digital Medicine. 8(1). 460–460.
4.
Han, Kai, Qiaoqi Sui, Yanbo Xu, et al.. (2025). circNRIP1 impairs tumorigenesis of colorectal cancer by sponging IGF2BP1 and decreasing NACC1 mRNA stability. Gastroenterology report. 13. goaf041–goaf041.
5.
Duan, Jin‐Ling, Ruixuan Wang, Xueyi Zheng, et al.. (2024). Deep learning model with pathological knowledge for detection of colorectal neuroendocrine tumor. Cell Reports Medicine. 5(10). 101785–101785. 3 indexed citations
6.
Jin, Xiaohan, Jin‐Ling Duan, Miaomiao Dai, et al.. (2024). METTL3 confers oxaliplatin resistance through the activation of G6PD-enhanced pentose phosphate pathway in hepatocellular carcinoma. Cell Death and Differentiation. 32(3). 466–479. 14 indexed citations
7.
8.
Zhou, Jie, Run‐Cong Nie, Yixin Yin, et al.. (2022). Genomic Analysis Uncovers the Prognostic and Immunogenetic Feature of Pyroptosis in Gastric Carcinoma: Indication for Immunotherapy. Frontiers in Cell and Developmental Biology. 10. 906759–906759. 7 indexed citations
9.
Duan, Jin‐Ling, Wei Chen, Juanjuan Xie, et al.. (2022). A novel peptide encoded by N6-methyladenosine modified circMAP3K4 prevents apoptosis in hepatocellular carcinoma. Molecular Cancer. 21(1). 93–93. 109 indexed citations
10.
Duan, Jin‐Ling, Minhua Deng, Mingxing Xu, et al.. (2022). Impact of WTAP in small HCC and paired adjacent non-neoplastic liver tissue on recurrence: A cohort study with external extension analysis. Frontiers in Cell and Developmental Biology. 10. 973548–973548. 2 indexed citations
11.
Deng, Minhua, Ning Wang, Zhiyong Li, et al.. (2022). FXR1 can bind with the CFIm25/CFIm68 complex and promote the progression of urothelial carcinoma of the bladder by stabilizing TRAF1 mRNA. Cell Death and Disease. 13(2). 170–170. 18 indexed citations
12.
Nie, Run‐Cong, Yun Wang, Jie Zhou, et al.. (2021). Efficacy of Anti-PD-1/PD-L1 Monotherapy or Combinational Therapy in Patients Aged 75 Years or Older: A Study-Level Meta-Analysis. Frontiers in Oncology. 11. 538174–538174. 19 indexed citations
13.
Duan, Jin‐Ling, Run‐Cong Nie, Jiewei Chen, et al.. (2021). Prognostic Model for the Risk Stratification of Early and Late Recurrence in Hepatitis B Virus-Related Small Hepatocellular Carcinoma Patients with Global Histone Modifications. Journal of Hepatocellular Carcinoma. Volume 8. 493–505. 5 indexed citations
14.
Chen, Li, Xiaohan Jin, Jie Luo, et al.. (2021). ITLN1 inhibits tumor neovascularization and myeloid derived suppressor cells accumulation in colorectal carcinoma. Oncogene. 40(40). 5925–5937. 16 indexed citations
15.
Cao, Chenhui, Ling Han, Kai Han, et al.. (2021). PPIP5K2 promotes colorectal carcinoma pathogenesis through facilitating DNA homologous recombination repair. Oncogene. 40(49). 6680–6691. 8 indexed citations
16.
Han, Kai, Feng‐Wei Wang, Chenhui Cao, et al.. (2021). Correction to: CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17. Molecular Cancer. 20(1). 3 indexed citations
17.
Zhang, Chi, Wei Shi, Weipeng Sun, et al.. (2020). Super-enhancer-driven AJUBA is activated by TCF4 and involved in epithelial-mesenchymal transition in the progression of Hepatocellular Carcinoma. Theranostics. 10(20). 9066–9082. 37 indexed citations
18.
Nie, Run‐Cong, Shuqiang Yuan, Ying-Bo Chen, et al.. (2020). Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials. BMC Cancer. 20(1). 421–421. 14 indexed citations
19.
Yuan, Shuqiang, Run‐Cong Nie, Shuman Li, et al.. (2019). Prognostic Factors and Recurrence Patterns in T4 Gastric Cancer Patients after Curative Resection. Journal of Cancer. 10(5). 1181–1188. 24 indexed citations
20.
Cai, Changjing, Xiaoqun Qin, Ziyi Wu, et al.. (2016). Inhibitory effect of MyoD on the proliferation of breast cancer cells. Oncology Letters. 11(6). 3589–3596. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gallina Kazobinka Breakdown of academic impact, for papers by Xuren Sun Breakdown of academic impact, for papers by Qijue Lu Breakdown of academic impact, for papers by Xianyu Hu Breakdown of academic impact, for papers by Fuao Cao Breakdown of academic impact, for papers by Juan Ramón Delgado Breakdown of academic impact, for papers by Huohui Ou Breakdown of academic impact, for papers by Mingyi Ju
Rankless by CCL
2026